Orchard Therapeutics plc Annual Nonoperating Income (Expense) in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Orchard Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2022.
  • Orchard Therapeutics plc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$12.7M, a 45.1% increase year-over-year.
  • Orchard Therapeutics plc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $29M.
  • Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$25.9M, a 681% decline from 2021.
  • Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2021 was -$3.32M, a 178% decline from 2020.
  • Orchard Therapeutics plc annual Nonoperating Income (Expense) for 2020 was $4.27M, a 40.8% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$25.9M -$22.6M -681% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-14
2021 -$3.32M -$7.59M -178% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $4.27M -$2.94M -40.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $7.21M +$1.71M +31% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $5.51M +$6.69M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$1.18M -$1.32M -954% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $138K Jan 1, 2016 Dec 31, 2016 20-F 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.